ARNA Financial Facts

General and administrative: 7.25M
Gain from valuation of derivative liabilities: 3.86M
See Full Income Statement

Total stockholders' equity: 80.42M
Other non-current assets: 4.05M
See Full Balance Sheet

Earnings History for Arena Pharmaceuticals, Inc. (ARNA)

  |   Expand Research on ARNA
Next EPS Date 8/8/13 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -69.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +4.6%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/10/11 Q111 -$0.35-$0.21 -$0.14$3.92M$3.29M N/A / N/A N/A +514.8% Details
11/9/10 Q310 -$0.31-$0.23 -$0.08N/AN/A N/A / N/A N/A +442.5% Details
3/11/11 Q410 -$0.23-$0.21 -$0.02$4.01M$4.81M N/A / N/A N/A +446.1% Details
3/14/12 Q411 -$0.16-$0.15 -$0.01$2.08M$3.49M N/A / N/A N/A +363.7% Details
11/9/11 Q311 -$0.16-$0.14 -$0.02$3.46M$3.37M N/A / N/A N/A +510.3% Details
8/9/11 Q211 -$0.16-$0.16 $0.00$3.26M$3.35M N/A / N/A N/A +492.9% Details
8/9/12 Q212 -$0.12-$0.08 -$0.04$22M$7.38M N/A / N/A N/A +12% Details
3/4/13 Q412 -$0.10-$0.03 -$0.07$1.94M$21.94M N/A / N/A N/A -0.5% Details
Like ARNA Earnings? Also take a look at VVUS, OREX, FB, GSK

ARNA Earnings News